The bone marrow microenvironment supports and regulates the proliferation and differentiation of hematopoietic cells. Dysregulated hematopoiesis in chronic myelogenous leukemia (CML) is caused, at least in part, by abnormalities in CML hematopoietic progenitors leading t o altered interactions with the marrow microenvironment. The role of the microenvironment itself in CML has not been well characterized. We examined the capacity of CML stroma t o support the growth of long-term culture-initiating cells (LTC-IC) obtained from normal and CML marrow. The growth of normal LTC-IC on CML stroma was significantly reduced compared with normal stroma. This did not appear t o be related t o abnormal production of soluble factors by CML stroma because normal LTC-IC grew equally well in Transwells above CML stroma as in Transwells above normal stroma. In addition, CML and normal stromal supernatants contained similar quantities of both growth-stimulatory (granulocyte colony-stimulating factor (CSF), interleukin-6, stem cell factor, granulocyte-macrophage CSF, and interleukin-1/31 and growth-inhibitory cytokines (transforming growth factor-p, macrophage inflammatory protein-la, and tumor necrosis factor-a). The relative proportion of different cell types in CML and normal stroma was similar. However, polymerase HE BONE MARROW (BM) microenvironment plays an important role in supporting and regulating the proliferation and differentiation of hematopoietic cells. The microenvironment is a complex system consisting of a variety of cell types, including stromal cells of nonhematopoietic, mesenchymal origin as well as hematopoietically derived stromal macrophages producing extracellular matrix components and hematopoietic growth factors. Hematopoietic progenitor cells in the marrow are in close contact with stromal elements and are subject to regulatory influences arising from the marrow microenvironment.'
chain reaction and fluorescence in situ hybridization studies showed the presence of bcr-ab/-positive cells in CML stroma, which were CD14+ stromal macrophages. To assess the effect of these malignant macrophages on stromal function, CML and normal stromal cells were separated by fluorescence-activated cell sorting into stromal mesenchymal cell (CD143 and macrophage (CD14+) populations. CML and normal CD14-cells supported the growth of normal LTC-IC equally well. However, the addition of CML macrophages t o normal or CML CD14-mesenchymal cells resulted in impaired progenitor support. This finding indicates that the abnormal function of CML bone marrow stroma is related t o the presence of malignant macrophages. In contrast t o normal LTC-IC, the growth of CML LTC-IC on allogeneic CML stromal layers was not impaired and was significantly better than that of normal LTC-IC cocultured with the same CML stromal layers. These studies demonstrate that, in addition t o abnormalities in CML progenitors themselves, abnormalities in the CML marrow microenvironment related to the presence of malignant stromal macrophages may contribute to the selective expansion of leukemic progenitors and suppression of normal hematopoiesis in CML. arising from the hematopoietic stem cell. It is characterized at the cytogenetic level by the Philadelphia chromosome (Ph') resulting from a translocation of chromosomes 9 and 22 [t(9:22) ]' and at the molecular level by the bcrlabl gene rearrangement.' Clinically, CML is characterized by an abnormal expansion of malignant bcrhbl-positive myeloid cells. The abnormal hematopoiesis in CML is related, at least in part, to abnormalities in the hematopoietic cells themselves leading to abnormal interactions between CML progenitors and stroma. Normal primitive progenitors adhere well to stroma and are usually quiescent when in contact with stroma.'. 4 In contrast, CML progenitors show reduced adherence to normal stromal layers'.' and are continuously proliferating even when in contact with stroma.' This may result from the abnormal function of important cytoadhesion receptors on CML It is not clear if and how the CML microenvironment contributes to dysregulated hematopoiesis in CML.
Tissue macrophages are derived from monocytes that originate from marrow hematopoietic progenitors. Because monocytes from patients with CML are derived from the malignant bcrhbl-positive clone, it is likely that a proportion of CML stromal macrophages may be of malignant origin. Indeed, pulmonary alveolar macrophages have been shown to be derived from the malignant clone in patients with CML. 9 We hypothesized that CML marrow stromal macrophages may be derived from the bcr/abl-positive clone, which may result in abnormalities in the function of CML BM stroma. Consequently, abnormal stromal function in CML may in part underlie the hematopoietic abnormalities observed in CML.
In this report, we characterized the function of the hematopoietic microenvironment in CML. We show that CML marrow stroma has a reduced ability to support growth of normal progenitors cultured in contact with stroma. Cells of malig- Stopped 4 months before study. t Stopped more than 1 month before study. nant origin, identified as stromal macrophages, are present in CML stroma and appear to be responsible for the abnormal stromal function. In contrast to normal hematopoietic progenitors, the growth of CML progenitors in contact with CML stroma is not impaired. These studies suggest that abnormalities in microenvironmental function may contribute to the selective expansion of malignant hematopoietic progenitors in patients with CML.
MATERIALS AND METHODS

BM Samples
Twenty-nine patients with CML and 25 normal healthy volunteers were studied. Patient characteristics are summarized in Table 1 . Twenty-eight patients were in the chronic phase of CML. One patient whose BM stroma was studied only for cellular composition was in accelerated phase of CML. Twenty-three patients had either never been treated or were being treated with hydroxyurea only. Five patients had received interferon-a in the past but had not received it for more than 1 month before evaluation. One patient had received Busulfan briefly at initiation of therapy but had not received it for more than 4 months before evaluation. Chronic and accelerated phases of CML were diagnosed according to published criteria." The majority of patients had either minimal or no BM fibrosis.
BM was obtained from patients with CML and from normal healthy volunteers after informed consent was obtained using guidelines approved by the Committee on the Use of Human Subjects at the University of Minnesota. Heparinized BM samples were obtained by aspiration from the posterior iliac crest. BM stromal layers were formed after 4 to 5 weeks of culture and were irradiated at 1,250 cGy using a Cesium irradiator to eliminate hematopoietic cells. Adherent cells, collected after digestion with 0.1% collagenase (Boehringer Mannheim, Indianapolis, IN), were subcultured at a concentration of 350,000 stromal cells/well in 2"eIl plates or 37,500 cells/well in 96-well plates (Costar, Cambridge, MA).4
Selection of Purified Progenitor Populations
Purified normal and CML progenitor populations were obtained from BMMNC using methods previously de~cribed.~."." Lineage negative cells were obtained from BMMNC by sequential counterflow centrifugation elutriation,"." sheep erythrocyte rosetting, and immunomagnetic bead dep1eti0n.I~ Alternatively, CD34' cells were selected from BMMNC using avidin-biotin immunoadsorbtion columns (CellPro Inc, Bothell, WA). The resultant populations were labeled with anti-CD34-phycoerythrin (PE) and anti-HLA-DR-fluorescein isothiocyanate (FITC) antibodies (Becton Dickinson, San JosC, CA) and sorted on a FACStafLUS laser flow cytometry system (Becton Dickinson) equipped with a CONSORT 32 computer system. Cells were selected for low vertical and horizontal light scatter properties and for expression of CD34 and HLA-DR antigens based on isotype control stains.
Progenitor Culture
Stromal Cultures
Stroma contact cultures. Normal CD34'HLA-DR-(DR-) or CML CD34'HLA-DR' (DR+) cells were plated in limiting dilutions on CML or normal stromal layers subcultured in 96-well plates (300, 100. 33, or 11 cells/well; 22 replicates per concentration). The absolute number of long-term culture-initiating cells (LTC-IC) was calculated as the reciprocal of the concentration of test cells that gave 37% negative wells, using Poisson statistics.15"' The growth of primitive normal and CML progenitors was also evaluated by plating 5,000 normal DR-or CML DR+ cells in direct contact with CML or normal stromal layers (or sorted CD14' and CD14-stromal cells [see below]) subcultured in 24-well plates.4," The number of colony-forming cells (CFC) generated after 5 weeks in stroma contact cultures then serves as a measure of the growth of LTC-IC. Results from bulk stroma contact cultures correlated well with the results of limiting dilution analyses.
Stroma noncontact cultures. A collagen-coated transwell insert with a 0.4-pn microporous filter membrane (Costar, Cambridge, MA) was placed above CML or normal irradiated stroma. Five thousand normal DR-or CML DR+ cells were plated in the Transwell insert and cultured for 5 weeks, after which CFC generation was evaluated."
Maintenance of cultures. Cultures were maintained for 5 weeks in a humidified atmosphere at 37°C and 5% CO2. Weekly media changes were performed by removing half the cell-free supernatant medium from stroma contact cultures and replacing it with fresh LTBMC medium. For stroma noncontact cultures, half the cell-free supernatant from the bottom well only was removed and replaced with fresh medium.
Evaluation of cultures. Cells harvested from stroma contact cultures after brief trypsinization or from transwell inserts of stroma noncontact cultures were replated in methylcellulose progenitor assays to determine the number of CFC present. To assess limiting dilution cultures, methylcellulose progenitor culture media was added directly to cells remaining in 96-well plates after removal of supernatants from the wells. Wells were scored for the presence or absence of CFC 2 weeks later.
Short-Term Methylcellulose Assay
Progeny of DRor DR' cells in LTBMC were plated in methylcellulose progenitor culture media supplemented with 3 IU recombi-For personal use only. on November 16, 2017. by guest www.bloodjournal.org From nant erythropoietin (Epoetin; Amgen, Thousand Oaks, CA) and 4 ng/ mL recombinant interleukin-3 (IL-3; a kind gift from Dr G. Wong, Genetics Institute, Boston, MA) as previously descrihed.I4 After 14 to 18 days, the cultures were assessed for the presence of colonyforming unit granulocyte-macrophage (CFU-GM), burst-forming unit-erythroid (BFU-E), and CFU-Mix colonies.
Measurement of Cytokine Production by Stromal Layers
Multiple aliquots of cell-free supernatants were collected from irradiated CML and normal BM stromal layers and from fluorescence-activated cell sorting (FACS)-sorted normal and CML CD14+ and CD14-stromal populations (see below) and were frozen at -70°C. Standard enzyme-linked immunosorbent assays (ELISAs) for granulocyte colony-stimulating factor (G-CSF), IL-6, stem cell factor (SCF), macrophage inflammatory protein-la (MIP-la), IL-IP, platelet-derived growth factor-AB (PDGF-AB; R&D, Minneapolis, MN), granulocyte-macrophage CSF (GM-CSF; Endogen, Boston, MA), transforming growth factor-0 l (TGF-P I; Genzyme, Cambridge, MA), and tumor necrosis factor-a (TNF-a; Boehringer Mannheim) were performed per the manufacturer's recommendations.
Evaluation of Cellular Composition of CML and Normal Stroma
CML and normal irradiated stromal cells were harvested by collagenase treatment. Cytospin preparations were stained with Wright-Giemsa to examine the general morphology and with cytochemical stains for nonspecific esterase, alkaline phosphatase, and Oil-Red-0. Stromal macrophages, fibroblasts, and adipocytes were identified on the basis of cellular morphology and cytochemical staining characteristics." Stromal macrophages were identified as cells with round, heterochromatic nuclei and vacuolated cytoplasm that stained brightly positive with nonspecific esterase. Stromal mesenchymal cells were identified as cells with larger, irregular euchromatic nuclei and blue cytoplasm that showed positive membrane staining with alkaline phosphatase. Adipocytes were identified as cells containing fat which stained positively with Oil-Red-0.
Evaluation for bcr/abl Gene Rearrangement in CML Stroma
Polymerase Chain Reaction (PCR) Analysis
Irradiated CML stromal layers containing 300,000 cells each were harvested by treatment with Trypsin and frozen at -70°C in phosphate-buffered saline (PBS). Total cellular RNA was extracted from thawed samples using the method of Chomczynski and Saachi." After reverse transcription, amplification of bcr/abl mRNA was performed by PCR using nested primers.",'0 Amplified samples were size separated by gel-electrophoresis, ethidium bromide stained, and photographed. Beta-actin controls were run for each sample. Amplified cDNA fragments were also electrophoretically transferred to a Nytran nylon membrane (Schleicher and Schuell, Keene, NH). Antisense oligonucleotide probes complementary to the bcr exon 2/ ab1 exon 2 (B2/A2) and bcr exon 3/abl exon 2 (B3/A2) were endlabeled using TDT (Bethesda Research Laboratories, Gaithersburg, MD) and '2P-dATP-Cordecypin (DuPontNew England Nuclear, Wilmington, DE) and hybridized to the membrane. After initial hybridization with the B2/A2 probe, membranes were stripped and reprobed with B3/A2. CML-derived K562 cells were used as positive controls and Raji cells and normal stromal cells were used as negative controls.
Fluorescent In Situ Hybridization (FISH) Analysis
Irradiated CML stromal layers were harvested by collagenase treatment. In some experiments, collagenase digested stromal layers were stained with anti-CD14 monoclonal antibody (Becton Dickinson) and FACS sorted t o obtain CD14 (macrophage-depleted stromal cell) populations (see below). FISH analysis for the rearranged bcr/abl fusion gene was performed using probes for the ab1 oncogene and the Mbcr region (Oncor, Gaithersburg, MD) to detect t(Y;22)(q34;q 1 I .2) in interphase cells. The ab1 probe consisted of two overlapping biotin-labeled cosmids that hybridize to 9q34. The Mbcr probe consisted of three overlapping digoxigenin-labeled cosmids that hybridize to the Mbcr at 22q l 1.2. The hybridization, washing, and analysis procedures have been described elsewhere." With this method, the ab1 probe had a green signal, the bcr probe had a red signal, and the bcr/abl fusion resulted in a fused red-green signal, which sometimes appeared yellow. Only interphase nuclei in which it was possible to account for both copies of the bcr and ab1 probes were scored. For each specimen. up to 200 consecutive qualifying interphase nuclei were scored and the final result was expressed as the percentage of cells with an apparent hcr-ab1 fusion signal. We have previously established the normal range for this probe mixture and used a cutoff of 210%-interphase cells with apparent bcr-ab1 fusion to classify any specimen as abnormal.
Separation of Stromal Macrophage and Mesenchymal Cell Populations
Stromal cell suspensions were prepared by collagenase treatment of nonirradiated stromal adherent layers from CML and normal LTBMCs. Cells were suspended in IMDM supplemented with 5% fetal bovine serum and EDTA (2.5 mmoVL), incubated with mouse Ig for 30 minutes to block nonspecific antibody binding, and then incubated for 30 minutes with either anti-CD14PE (Becton Dickinson) or control mouse IgG2bPE. Antibody-labeled cells were filtered through a Nitex mesh (1 00-pm pore size; Tetco Inc, Monterey Park, CA) to remove cell aggregates and then FACS sorted into CD14' and CD14-populations. Normal and CML CD14+ and CD14-cells were either plated separately in wells of 24-well plates at a concentration of 50,000 cells per well or 50,000 CD14' and 50,000 CD14cells were mixed together to reconstitute normal or CML stroma. Alternatively, 50,000 normal CD14-cells were mixed with 50,000 CML CD14+ cells and 50,000 CML CD14-~ with 50,000 normal CD14+ cells to make hybrid stromal layers. The cells were grown in LTBMC medium for 3 to 4 weeks until CD14 cells reached maximal confluence and were then irradiated at 1,250 cCy.
Statistical Analysis
Results of data obtained from multiple experiments were reported as the mean ? 1 SEM. Significance levels were determined by twosided Student's t-test analysis.
RESULTS
Preparation of Stromal Layers
Stromal layers were prepared by plating normal or CML BM in LTBMC for 4 to 5 weeks until a confluent adherent stromal layer was formed. The formation of confluent stromal layers from CML BM required a higher number of cells (1.6 X 1 06/cm2) than was required for the formation of normal stromal layers ( I X 106/cm2). Confluent layers were irradiated at 1,250 cGy to eliminate hematopoietic cells. Irradiated stromal layers were harvested with collagenase and subcultured in 24-well and 96-well plates using a constant number of stromal cells per well (350,000 and 37,500 cells per well, respectively) to ensure comparability between normal and CML stroma. 
Growth of Normal Primitive Progenitors on CML Stroma
To assess the growth of normal LTC-IC on CML stroma, normal DRcells were plated in limiting dilutions on CML and normal stroma subcultured in 96-well plates and grown in LTBMC for 5 weeks to assess the absolute number of LTC-IC that could be induced to grow. These studies showed that the number of LTC-IC induced to differentiate/proliferate by CML stroma was significantly lower than that induced by normal stroma ( P < .03 ; Fig 1) . In addition, 5,000 normal DR-cells were plated on CML and normal stromal layers subcultured in 24-well plates and grown in LTBMC for 5 weeks. A significantly reduced number of CFC was produced after 5 weeks of culture on CML stroma compared with normal stroma (P < .001; Fig l) . The average number of CFC generated from each LTC-IC (calculated by dividing the number of CFC generated from 5,000 DRcells after 5 weeks of LTBMC by the number of LTC-IC detected by LDA within 5,000 DRcells) for normal stroma (5.0 z 0.9)
was not significantly different than that for CML stroma (5.7 t-1.0). The presence of CML stromal cells did not affect the growth of normal CFC in the methylcellulose progenitor assay (134.0 2 20.7 and 141.6 -C 17.1 BFU-E, 83.9 +-4.5 and 81.3 2 7.0 CFU-GM, and 18.9 2 1.2 and 19.4 5 0.8
Cm-Mix per 5,000 DR' cells in the presence of CML and normal stroma, respectively). Although there was varjability in the LTC-IC frequency in progenitor populations obtained from different normal donors, normal progenitors from a single donor showed similar growth on different normal stromal layers. Experiments evaluating the hematopoietic supportive capacity of CML stroma were therefore always performed concomitantly with normal stroma controls. The progenitor growth on each individual CML stroma studied was expressed as a percentage of that on the corresponding normal stroma control for that experiment. These studies suggest therefore that growth of normal primitive progenitors is impaired when cocultured with stroma from certain CML patients. There was considerable variability in the LTC-IC supportive capacity of individual CML stromal layers (Fig  I) . In this limited sample size, we did not find a correlation between the stage or duration of CML or presence or absence of marrow fibrosis with the functional capacity of the stromal layers.
Normal primitive progenitors were also grown in Transwell inserts with a 0.4-pm microporous membrane, which prevents cell contact with the underlying CML or normal stroma but allows free diffusion of soluble factors. As we have previously de~cribed,'~ significantly more CFC were generated when normal DR-cells were cultured in stroma noncontact cultures than in stroma contact cultures using normal stroma. Interestingly, normal DR-cells gave rise to similar numbers of CFC when cultured in Transwells above CML as compared with normal stroma (Fig l) , suggesting that reduced growth of normal DR-cells cultured in contact with CML stromal layers may not be related to abnormal production of soluble growth factors.
Growth Factor Production by CML Stroma
Growth factor production by CML and normal stroma was assessed by standard ELISAs of stromal supernatants. G-CSF, IL-6, and TGF-P levels in CML and normal stromal supernatants were not significantly different, whereas GM-CSF, IL-1, and PDGF were undetectable in both ( Table 2) . Although reduced levels of TNF, SCF, and MIP-la were observed in CML stromal supernatants, these differences were not found to be statistically significant. Where available, we compared cytokine levels and the capacity of the stromal feeders to support normal primitive progenitor growth. In this limited number of samples we did not find a correlation between cytokine production and the ability of individual stromal layers to support normal primitive progenitor growth (n = 12). These results further suggest that reduced growth of normal progenitors on CML stroma may be related to mechanisms other than reduced production of growth-stimulatory cytokines or increased production of growth-inhibitory cytokines by CML stromal layers.
Cellular Composition of CML Stroma
We next investigated whether the defect in hematopoietic supportive capacity of CML stroma was the result of abnormalities in its cellular composition. CML or normal stromal layers were harvested with collagenase to obtain single-cell suspensions. The relative number of stromal macrophages and nonhematopoietic stromal mesenchymal cells, including adipocytes, was assessed by differential cell count after staining cytospin preparations with Wright-Giemsa stain and various cytochemical stains.'* No significant differences in the cellular composition of CML and normal stromal layers were seen ( Table 3) .
bcr/abl Rearrangement Is Present in CML Stromal
Cells
Irradiated CML stromal layers were harvested and analyzed for the presence of the bcr/abl gene rearrangement, characteristic of the malignant clonal population in CML. Lack of colony growth in methylcellulose progenitor cultures confirmed the absence of hematopoietic progenitors (data not shown). Reverse transcription-PCR (RT-PCR) of irradiated stromal layers indicated the presence of malignant cells (n = 4; Fig 2) . These results were confirmed by FISH analysis. These results showed the presence of a large proportion of bcr/abl-positive cells in irradiated CML stroma (56.3% 2 6.5%, n = 7; Table 4 ). The proportion of CD14+ macrophages in CML stroma (57.3% ? 3.1%, as detected by FACS) was similar to the proportion of cells with b d a b l gene rearranged cells (56.3% ? 6.5%, as detected by FISH). To further demonstrate that the bcr/abl rearranged cells were macrophages, we depleted CML stroma of macrophages by FACS sorting. CD14-cells were reevaluated for the bcr/abl rearrangement by FISH. The percentage of bcr/abl rearranged cells in the CD14-population was 6% and 13%, as compared with 46% and 53%, respectively, in the undepleted population in two separate experiments. These studies indicate that CD14+ stromal macrophages are malignant. Macrophages 62.9 f 1. 
CML Macrophages Are Responsible for the Impaired Stromal Function in CML
To evaluate whether the malignant macrophage population was responsible for the defective function of CML stroma, CML and normal stromal layers were separated into CD14' (stromal macrophage) and CD14-(stromal mesenchymal cell) populations by FACS sorting. The separated populations were cultured over a period of 3 to 4 weeks, allowing CD14-cells to grow to maximum confluence. irradiated at 1,250 cGy, and subsequently evaluated for their ability to support the growth of normal LTC-IC. As was seen for unmanipulated normal and CML stromal layers, CML stromal layers reconstituted by mixing CD14-and CD 14' populations together supported normal LTC-IC growth significantly less well than reconstituted normal stro- FISH analysis was performed on CML stromal layers to detect the presence of cells containing the bcr/abl gene rearrangement. Cytospin preparations were made from single-cell suspensions of CML stromal layers and labeled with digoxigenin-labeled bcr (green signal) and biotin-labeled ab1 (red signal) probes. Cells were scored as being positive for the bcr/abl fusion gene if there was either close proximity of the red and green signals or a fusion yellow signal. A cutoff of ~1 0 % interphase cells with apparent bcr/abl fusion was used to classify any specimen as being abnormal.
Abbreviation: NA, not assessed. In contrast, FACS-purified CML and normal CD14 mesenchymal cells supported the growth of LTC-IC equally well (Fig 3) . The ability of CD14' cells from CML or normal stroma to support normal LTC-IC growth was low. However, no differences were seen between CML and normal stroma-derived CD14' cells (136.8 5 26.9 CFC per 2,500 DR-cells on normal CD14' cells and 157.3 & 23.3 per 2,500 DR-cells on CML CD14" cells). Reconstituted stroma containing a mixture of CML CD14' cells and normal CD14-cells had significantly impaired hematopoietic supportive ability, whereas the mixture of normal CD14' cells and CML CD14-cells had normal hematopoietic supportive function. These results suggest that CML macrophages in the context of CD14-strom, ' I I mesenchymal cells are responsible for the impaired function of CML stroma.
No significant differences were found in the amounts of IL-ID. PDGF, TGF-D, and MIP-la produced by macrophages from CML or normal stroma (Table 5 ). IL-6 and TNF-a! production by CML macrophages was higher than that for normal stromal macrophages, but the differences were not statistically significant. Production of the abovementioned cytokines by CML or normal CD14.. stromal cells or by mixtures of CML and normal CD14-and CD14' cells was not significantly different. Therefore, the observed adverse effect of CML macrophages on CML or normal CD14-stromal cell function cannot be readily explained by significantly altered cytokine production.
Growth of CML Primitive Progenitors on CML Stroma
Finally, we studied the ability of CML stroma to support the growth of CML LTC-IC. We have previously shown placed in suspension after collagenase treatment, stained with anti-CD14 monoclonal antibody, and FACS sorted into CD14' (macrophage) and CD14-populations. The sorted normal and CML CD14-and CD14+ cells were either cultured separately or were mixed as shown. Sorted CML CD14' macrophages were mixed with normal CD14' cells and normal CD14' macrophages were mixed with CML CD14 cells. A total of 2,500 normal DR-cells were cultured in LTBMC media on sorted CML and normal stromal cells for 5 weeks. Cells were harvested at week 5 and CFCs were assayed in methylcellulose progenitor culture. For all cultures, the number of CFCs generated from DR cells after culture was expressed as a percentage of the number of CFCs generated on normal controls (mixture of normal CD14' and normal CD14-stromal cells) for each experiment. Results represent the mean 2 SEM of pooled experiments ( n = 4). Significance levels compared with colony output on normal controls; * P < .05. The average colony output per 2,500 DR-cells on normal stroma controls was 243. 8 2 19 .5 at week 5 . Normal DRcells cultured in stroma-free wells in LTBMC media yielded n o CFC at week 5.
that, it1 contrast to normal progenitors, malignant CML LTC-IC and CFC 31-63 present within the DR' BM fraction." Therefore, we compared the growth of CML DK' cells on allogeneic CML stronul layers to their growth on normal stromal laycrx. We showed that. in contrast to normal LTC-IC, the growth of CML LTC-IC in limiting dilutions in contact with CML stroma was not reduced compared with normal stroma (Fig 4) . Similar results were obtained when CML D R ' cells were culturcd in contact with CML and normal stromal laycrs subcultured in 34-wcll plates for S weeks and the number of CFC generated was evaluated (Fig Stromal macrophages were separated from CML and normal stromal cell suspensions by selecting CD14 cells by FACS, cultured in LTBMC medium for 2 to 3 weeks, and then irradiated at 1,250 cGy. Culture supernatants were collected 2 days after a scheduled weekly media change and assayed for the above cytokines by ELISA (n = 3). Cytokines were undetectable by ELISA in fresh LTBMC medium, with the exception of TGF-P (2.1 ng/mL). Values are the mean i SEM, with the range in parentheses. 4). The growth of CML LTC-IC in contact with CML stroma was significantly better than the growth of normal progenitors on the same CML stromal layers ( I ' = ,006). As for normal progenitors, CML LTC-IC cultured in Transwell\ above CML and normal stromal layers gave rise to similar numbers of CFC after 5 weeks. These results suggest that CML LTC-IC are not sub.ject to similar inhibitory influences as are normal progenitors whose growth is impaired when cultured in contact with CML stroma.
DISCUSSION
Ordered hematopoiesis is believed to depend on the intcraction o f primitive and morc differentiated hclnatopoietic progenitors with specific cellular and extracellular elemcnts ofthe BM hematopoietic microerlvironmcnt. However, regulatory mechanisms operativc in normal hematopoiesis do not appear to be opcrative in CML. Malignant CML hcmatopoietic progenitors clearly have intrinsic defects leading to ; h normal interactions with normal stroma."' Surprisingly, there is little information available regarding the function o f the BM microenvironment in CML."." The prewnt study suggests that marrow stromal function is abnormal in CML as a result of the presencc of malignant stromal macrophages. Our rewlts suggest that microenvironmental dysfunction may contribute to the selective outgrowth of malignant cells and suppression of normal hernatopoieais in CML.
We show that marrow stroma from a significant proportion of CML patients has reduced ability to support the growth of normal LTC-IC. In contrast, growth of progenitors at a distance from CML stroma was normal, indicating that production of soluble hematopoietic growth factors by CML stroma may be normal. Although there were trends towards reduced levels of TNF, SCF, and MIP-la in CML stromal supernatants, these differences were not found to be statistically significant. This finding is consistent with previous studies indicating that stromal cells from patients with chronic-phase CML produce normal levels of various growth-stimulatory and growth-inhibitory c y t o k i n e~. *~-~~ The observed decreased growth of LTC-IC, occurring only under conditions of close contact between stroma and progenitors, may reflect either imbalances in growth factors bound to stroma or abnormal expression of adhesive ligands in CML stroma. Although our preliminary unpublished observations failed to demonstrate significant differences in the expression of extracellular matrix components such as fibronectin, thrombospondin, and collagen type 4 or cell surface adhesion molecules such as ICAM, VCAM, and ELAM between CML and normal stroma, differences in the conformational states" or alternatively spliced forms of these c o r n p o n e n t~~~~~~ that have not yet been assessed may account for the observed altered stromal function. In addition, other extracellular ma-trix components such as specific proteoglycans3' may be abnormal or absent from CML stroma. Furthermore, a variety of growth factors are either membrane anchored3' or extracellular matrix bound.3z These immobilized cytokines can bind and activate receptors on adjacent cells and result in the delivery of growth regulatory signals in a spatially localized manner to adherent cells. Altered capacity of extracellular matrix components in CML stroma to bind important hematopoietic growth factors or altered expression of membrane-anchored cytokines may then lead to abnormal growth signaling despite normal levels of cytokines being present in stromal supernatants.
In contrast to normal hematopoietic progenitors that adhere well to normal stroma, CML progenitors show reduced adhesion to stroma and proliferate continuously even when in contact with stroma, suggesting that they are not subject to negative regulation by stroma. ' We show here that the growth of CML progenitors in contact with CML stroma is not reduced compared with their growth on normal stroma and is significantly better than that of normal progenitors on CML stroma. In contrast, CML and normal progenitors grow equally well when cultured separated from either CML or For personal use only. on November 16, 2017. by guest www.bloodjournal.org From normal stroma. The abnormalities in the CML marrow microenvironment described here may therefore contribute to the abnormal expansion of the malignant Ph'-positive clone and suppression of coexisting normal progenitors in CML. Because contact with CML stroma inhibits normal but not malignant progenitor growth, the Ph'-negative progenitors may proliferate less than their malignant counterparts, which may result in a selective growth advantage for the malignant progenitors.
PCR and FISH analysis of CML stroma irradiated to eradicate endogenous hematopoiesis showed the presence of bcrl abl-positive cells. Based on previously published studies, CML stromal fibroblasts are likely to be nonmalignant.",3J However, there is some evidence that macrophages may be derived from the Ph'-positive clone.' We separated stromal macrophages and mesenchymal cells by FACS and confirmed that stromal macrophages but not mesenchymal cells are malignant. CML stromal mesenchymal cells, separated from malignant CML macrophages, supported normal hematopoiesis to the same extent as did normal stromal mesenchymal cells. The addition of CML macrophages resulted in diminished support of normal hematopoietic progenitors by both CML and normal stromal mesenchymal cells. This finding shows that the defective hematopoietic supportive function of CML stroma depends on the interaction of malignant stromal macrophages with nonhematopoietic stromal mesenchymal cells. The mechanism(s) by which CML stromal macrophages causes altered stromal function cannot be readily explained on the basis of altered production of stimulatory or inhibitory hematopoietic growth factors or of mesenchymally active cytokines. Altered cell-cell interactions between the malignant macrophages and other stromal cells or cytokines other than those studied here may be responsible for the adverse effect of CML macrophages on mesenchymal cells. Such interactions may then affect cytokine production and/or binding, cell adhesion molecule expression, or extracellular matrix production by neighboring stromal mesenchymal cells, thereby leading to the above described defects. Abnormal function of various adhesion receptors has been described in CML including abnormalities in PI integrin receptors'.' and the LFA-3 receptor." Such defects may be present in CML macrophages. Because adhesion receptors, including the P I integrins, play an important role in extracellular matrix deposition and remodeling,26 such defects may underlie the macrophage-mediated stromal abnormalities observed here.
A higher number of CML BM cells was required to obtain confluent stromal layers. This finding is consistent with the observation that the CFU-F frequency is reduced in CML BM, likely as a result of dilution by the expanded number of myeloid cells.23 However, because we compensated for this by replating an equal number of CML and normal stromal cells in each experiment, the observed differences in stromal function are not caused by a decreased total number of stromal cells in CML stromal feeders. In contrast to some earlier reports, we did not find a consistent increase or decrease in the number of reticular cells, adipocytes, or macrothe observed functional abnormalities of CML stromal layers were not related to alterations in the relative proportions of phages37.38 In ' CML stromal layers. Our results indicate that the stromal macrophages and mesenchymal cells, including adipocytes.
The abnormalities in the CML marrow microenvironment described here should be taken into account when gene insertion into stem cells and/or expansion of stem cells are attempted. Indeed, the use of autologous CML marrow stroma to support ex vivo expansion or retroviral gene transduction of selected benign stem cells in CML may necessitate the removal of CD 14 macrophages to improve the hematopoietic supportive capacity of autologous feeders.'""' In addition, our observation that stromal macrophages are bcrhbl positive needs to be taken into account when analyzing BM samples early post-BMT for minimal residual disease. PCR positivity may reflect persistent malignant stromal macrophages that survive for several months after BM transplantation." This finding may explain why some patients who remain bcr/abl positive by PCR early after BM transplantation do not develop recurrent
In conclusion, we show that the BM microenvironment in CML is abnormal and may contribute to clinical abnormalities observed in this disease. Malignant stromal macrophages appear to be responsible for the observed defects in stromal function. Further studies examining the nature of the defect and the mechanisms by which macrophages affect stromal function may provide significant new insights into the pathophysiology of CML and lead to new therapeutic approaches for this disease.
